Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 10015

BillFederalHouseIn Committee
To amend the Internal Revenue Code of 1986 to modify health savings accounts, to amend the Public Health Service Act to provide for hospital and insurer price transparency, and for other purposes.
About This Bill
Committee
Latest Action · August 3, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, the Judiciary, Armed Services, Veterans' Affairs, Foreign Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress
119th (2025–2027)
Introduced
August 3, 2026
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
# Summary of H.R. 10015: Great American Healthcare Act This bill makes sweeping changes to healthcare financing and price transparency in the United States. The legislation expands Health Savings Accounts (HSAs) by increasing contribution limits, allowing broader use of funds for wellness expenses like fitness memberships and healthy food, and permitting rollovers to family members or special savings accounts. It also removes certain healthcare coverage requirements tied to HSA eligibility and allows HSA funds to be rolled over from flexible spending accounts and health reimbursement arrangements. The bill significantly strengthens price transparency requirements for hospitals, diagnostic laboratories, imaging services, and ambulatory surgical centers, requiring them to publish detailed pricing information by January 1, 2027. Health insurers must disclose negotiated rates and claims data to group health plans, with strict deadlines and civil penalties up to $300 per day or millions of dollars for persistent noncompliance. The legislation also requires health plans to provide detailed explanations of benefits and itemized bills within specified timeframes. For prescription drugs, the bill maintains current Medicare payment rates for cancer and complex therapies by requiring manufacturers to pay rebates when drug prices fall below negotiated maximum fair prices. Additionally, it expands access to certain prescription medications by allowing pharmacists and other healthcare professionals to dispense and administer drugs for minor conditions under new protocols. The bill also makes technical changes to Federal Reserve banking rules regarding earnings on reserve balances.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.